Fernando J Martinez Selected Research

Idiopathic Pulmonary Fibrosis

11/2022	A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.
4/2022	Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial.
1/2022	Association of circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis.
1/2022	Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary Fibrosis.
12/2021	Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial.
11/2021	Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
1/2021	Antimicrobial Therapy and Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis-Reply.
1/2021	Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
1/2021	Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis.
3/2020	Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando J Martinez Research Topics

Disease

203	Chronic Obstructive Pulmonary Disease (COPD) 07/2022 - 01/2004
63	Idiopathic Pulmonary Fibrosis 11/2022 - 01/2003
35	Emphysema 04/2022 - 04/2005
22	Pneumonia (Pneumonitis) 12/2021 - 03/2002
21	Disease Progression 01/2022 - 06/2006
19	Fibrosis (Cirrhosis) 01/2022 - 09/2003
15	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2022 - 01/2003
14	Lung Diseases (Lung Disease) 12/2022 - 01/2003
14	Dyspnea (Shortness of Breath) 07/2022 - 06/2006
14	Asthma (Bronchial Asthma) 10/2021 - 01/2004
14	Chronic Bronchitis 01/2020 - 01/2004
13	Inflammation (Inflammations) 01/2022 - 04/2009
12	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2003
11	Infections 01/2018 - 03/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 06/2020 - 06/2014
7	Idiopathic Interstitial Pneumonias 01/2021 - 01/2003
6	COVID-19 12/2022 - 01/2020
6	Pulmonary Hypertension 01/2021 - 08/2007
6	Bronchiectasis 01/2019 - 01/2004
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 09/2013
5	Gastroesophageal Reflux (GERD) 01/2020 - 07/2013
4	Lung Injury 12/2012 - 03/2008
3	Cough 01/2022 - 01/2011
3	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2021
3	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2004
3	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2021 - 01/2019
3	Respiratory Tract Infections (Respiratory Tract Infection) 10/2018 - 01/2004
3	Myocardial Infarction 01/2018 - 01/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 03/2012
3	Lung Neoplasms (Lung Cancer) 06/2010 - 04/2005
2	Chronic Disease (Chronic Diseases) 12/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

41	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 09/2007
35	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2012
29	Bronchodilator Agents (Bronchodilators)IBA 04/2022 - 10/2007
28	GoldIBA 01/2022 - 12/2009
24	vilanterolIBA 01/2022 - 04/2013
24	fluticasone furoate FDA Link 01/2022 - 04/2013
18	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 11/2016
15	Oxygen (Dioxygen)IBA 07/2021 - 06/2006
14	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 11/2016
13	GSK573719IBA 01/2022 - 05/2018
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
13	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2004
12	CytokinesIBA 12/2022 - 05/2005
11	RoflumilastIBA 01/2021 - 08/2009
11	Carbon MonoxideIBA 01/2021 - 09/2003
10	MacrolidesIBA 12/2021 - 03/2002
10	Muscarinic AntagonistsIBA 06/2021 - 01/2012
9	Azithromycin (Zithromax)FDA LinkGeneric 12/2021 - 01/2007
8	Pharmaceutical PreparationsIBA 01/2020 - 07/2005
7	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 01/2020
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2012
6	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 08/2021 - 10/2018
6	Immunoglobulin G (IgG)IBA 10/2020 - 04/2009
6	SuspensionsIBA 04/2020 - 11/2016
6	SmokeIBA 01/2020 - 12/2005
5	nintedanibIBA 04/2022 - 01/2017
5	Acetylcysteine (Siran)FDA LinkGeneric 01/2019 - 05/2012
5	Tiotropium Bromide (Spiriva)FDA Link 01/2019 - 08/2009
5	Azathioprine (Imuran)FDA LinkGeneric 01/2019 - 05/2012
5	Prednisone (Sone)FDA LinkGeneric 01/2019 - 05/2012
5	CollagenIBA 01/2017 - 05/2003
5	Bleomycin (Blenoxane)FDA LinkGeneric 12/2012 - 02/2005
4	LigandsIBA 12/2022 - 04/2007
4	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 09/2010
4	SteroidsIBA 01/2021 - 02/2017
4	C-Reactive ProteinIBA 01/2019 - 08/2015
4	Biological ProductsIBA 01/2019 - 01/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2018 - 03/2012
4	Messenger RNA (mRNA)IBA 11/2015 - 08/2010
3	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2020
3	Doxycycline (Periostat)FDA LinkGeneric 11/2021 - 05/2004
3	Hemoglobins (Hemoglobin)IBA 07/2021 - 06/2006
3	Fibrinogen (Factor I)FDA Link 04/2021 - 01/2019
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 09/2010
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2016
3	Simvastatin (Zocor)FDA LinkGeneric 10/2020 - 06/2014
3	QuercetinIBA 01/2020 - 09/2010
3	GlucocorticoidsIBA 01/2020 - 06/2014
3	Sildenafil Citrate (Viagra)FDA Link 12/2019 - 06/2013
3	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2019 - 01/2017
3	ChemokinesIBA 04/2019 - 09/2004
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2019 - 08/2016
3	Metalloproteases (Metalloproteinases)IBA 11/2018 - 01/2012
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016 - 08/2009
3	MicroRNAs (MicroRNA)IBA 11/2015 - 01/2011
3	ambrisentan FDA Link 11/2015 - 05/2013
3	Interleukin-13IBA 05/2014 - 06/2004
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2012 - 03/2008
2	MucinsIBA 12/2022 - 11/2021
2	Monoclonal AntibodiesIBA 11/2022 - 01/2019

Therapy/Procedure

107	Therapeutics 03/2022 - 01/2004
18	Nebulizers and Vaporizers (Inhaler) 03/2022 - 05/2018
15	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 11/2016
12	Pneumonectomy (Lung Volume Reduction) 01/2012 - 04/2005
6	Drug Therapy (Chemotherapy) 10/2021 - 08/2004
6	Lung Transplantation 01/2019 - 04/2005
5	Precision Medicine 09/2018 - 01/2016
4	Traction 01/2019 - 06/2008
3	Dry Powder Inhalers 01/2020 - 11/2016